Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000116964 | SCV000151082 | benign | not specified | 2016-05-04 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000116964 | SCV000229190 | benign | not specified | 2014-05-23 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000514021 | SCV000610946 | benign | not provided | 2017-05-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000336184 | SCV000636623 | benign | Kleefstra syndrome 1 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312105 | SCV000846678 | benign | Inborn genetic diseases | 2016-05-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000514021 | SCV001842106 | benign | not provided | 2019-08-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000336184 | SCV002798465 | likely benign | Kleefstra syndrome 1 | 2021-08-24 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000514021 | SCV005318128 | benign | not provided | criteria provided, single submitter | not provided |